GREGORY S CURHAN
CIK 1263244 · Chief Financial Officer · last filed 2026-05-26
GREGORY S CURHAN is a Chief Financial Officer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for SER, was dated May 26, 2026. Across all open-market trades the lifetime net is +$9.5K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
8
$9.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SER | Chief Financial Officer | — | $1.84 | — | $0 | 2 | 2026-05-26 |
| Elicio Therapeutics, Inc. (ANGN) Delisted | See Remarks | 4,000 | $10.00 | $40.0K | $9.5K | 2 | 2022-03-04 |
| Merriman Holdings, Inc (MERR) Delisted | Executive Vice President | — | — | — | $0 | 2 | 2008-05-06 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | SER | Grant (A) | — | $0 | EDGAR |
| 2024-08-20 | SER | Grant (A) | — | $0 | EDGAR |
| 2022-03-04 | Elicio Therapeutics, Inc. (ANGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-16 | Elicio Therapeutics, Inc. (ANGN) Delisted | Buy (P) | +4,000 | $9.5K | EDGAR |
| 2009-03-13 | — | Grant (A) | — | $0 | |
| 2008-11-05 | — | Other (J) | — | $0 | |
| 2008-05-06 | Merriman Holdings, Inc (MERR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-02-19 | Merriman Holdings, Inc (MERR) Delisted | Grant (A) | — | $0 | EDGAR |